Are There Any Specific Genetic Mutations That Predict Response to Immunotherapy?
Certain genetic mutations have been identified that can predict a patient's response to immunotherapy. For example, tumors with a high mutational burden or specific mutations in the mismatch repair genes tend to respond better to checkpoint inhibitors. Identifying these mutations can help in selecting patients who are more likely to benefit from immunotherapy.
